Related Experiment Video

Updated: Sep 1, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.2K

T-CUS and Low-Count T-LGLL: Diagnostic Uncertainties and the Unmet Need for Markers of Disease Progression

Teramo Antonella1,2, Trimarco Valentina1, Buson Elena1,2

  • 1Department of Medicine, Hematology Unit, University of Padova, Padova, Italy.

International Journal of Laboratory Hematology
|December 26, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.3K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.0K

Related Experiment Videos

Last Updated: Sep 1, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.2K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.3K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.0K

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

Articles linked to this work by shared authors, journal, and citation graph.

Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus.

Cancers·2026

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Blood·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

Cancers·2026

Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study.

Blood advances·2025

Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168.

Cancers·2025

Characterizing Red Blood Cell Rheological Parameters Using Automated Syllectometry: Conventional and Exploratory Multivariate Analyses.

International journal of laboratory hematology·2026

Verification of Patient Result Comparability Among Nine Hematology Analyzers Using the CLSI EP31-A-IR Guideline: A Four-Year Experience.

International journal of laboratory hematology·2026

Is It Time to Raise the Threshold for Critically Low Fibrinogen? Insights From a Retrospective, Consecutive-Case Cohort Study of Low Fibrinogen due to Various Causes.

International journal of laboratory hematology·2026

Functional Assessment of Platelet-Derived Phospholipid Activity in Pooled Normal Plasmas by Low-Phospholipid Thrombin Generation Assay and Its Impact on Lupus Anticoagulant Mixing Tests.

International journal of laboratory hematology·2026

Utilizing Inhibitor Screening Assay Results to Predict Bethesda Titers in Patients With Hemophilia A: Cost-Effective Strategy in Resource-Constrained Setting.

International journal of laboratory hematology·2026

ICSH Guidance on Bone Marrow Examination and Reporting.

International journal of laboratory hematology·2026

Artificial Intelligence-Driven Multiomics and Clinical Investigation Identify Macrophage Migration Inhibitory Factor as a Pan-Cancer Biomarker.

Phenomics (Cham, Switzerland)·2026

Human papilloma virus as causal in breast cancer.

Frontiers in oncology·2026

Noninvasive Prediction of Clinically Significant Portal Hypertension in Hepatocellular Carcinoma: A Tumor-Adjusted Model.

The American journal of gastroenterology·2026

Precision Selection for Targeted Radionuclide Therapy in Prostate Cancer: Biparametric MRI Radiomics Combined with Serum Bone Turnover Biomarkers for Predicting Postoperative Bone Metastasis.

Cancer biotherapy & radiopharmaceuticals·2026

[Prostate-Preserving Curative Surgery for Isolated Peritoneal Recurrence with Seminal Vesicle Invasion Following Sigmoid Colon Cancer Resection-A Case Report].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

[Association Between Tertiary Lymphoid Structures and Intratumoral Microbiota in Lung Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us